Cigna Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Buy
+3,525
New +$182K 0.03% 411
2024
Q4
Sell
-3,367
Closed -$225K 472
2024
Q3
$225K Hold
3,367
0.04% 416
2024
Q2
$400K Sell
3,367
-130
-4% -$16.5K 0.07% 261
2024
Q1
$373K Hold
3,497
0.07% 288
2023
Q4
$348K Sell
3,497
-79
-2% -$6.64K 0.07% 293
2023
Q3
$369K Sell
3,576
-460
-11% -$51.3K 0.08% 256
2023
Q2
$491K Hold
4,036
0.09% 223
2023
Q1
$620K Sell
4,036
-97
-2% -$16K 0.12% 169
2022
Q4
$743K Sell
4,133
-48
-1% -$7.85K 0.15% 142
2022
Q3
$494K Sell
4,181
-274
-6% -$41.6K 0.11% 191
2022
Q2
$637K Sell
4,455
-1,631
-27% -$233K 0.13% 164
2022
Q1
$1.05M Sell
6,086
-1,854
-23% -$312K 0.13% 154
2021
Q4
$2.02M Sell
7,940
-2,861
-26% -$837K 0.16% 109
2021
Q3
$4.16M Buy
10,801
+8,276
+328% +$3.05M 0.31% 62
2021
Q2
$594K Buy
2,525
+329
+15% +$58.8K 0.04% 386
2021
Q1
$287K Sell
2,196
-504
-19% -$73K 0.02% 610
2020
Q4
$282K Buy
+2,700
New +$273K 0.02% 578

Other funds holding MRNA

Cigna Investments's MRNA Position: Q2 2026 in Review

Cigna Investments opened a new position in Moderna (MRNA) in Q2 2026: 3,525 shares worth $247K. The stake represents 0.03% of the portfolio and ranks #411 among its holdings. This is a return to the name: Cigna Investments previously reported a position in MRNA as recently as Q3 2024.

Cigna Investments first reported a position in MRNA in Q4 2020 and has held it in 17 quarters since. The position peaked at $4.16M in Q3 2021. 131 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Cigna Investments held 3,525 shares of Moderna worth $247K as of Q2 2026.
  • Moderna was a new Cigna Investments position in Q2 2026.
  • Moderna made up 0.03% of Cigna Investments's portfolio in Q2 2026, its #411 holding.
  • Cigna Investments first reported a position in Moderna in Q4 2020 and has held it in 17 quarters since.
  • Cigna Investments's Moderna position peaked at $4.16M in Q3 2021.
  • 131 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.